Serologic Testing for Human Immunodeficiency Virus Antibodies

Mayo Clinic Proceedings

Volumn 63, Issue 4, 1988, Pages 373-380

  STECKELBERG, JAMES M ^a   COCKERILL, FRANKLIN R ^a  

^a Division of Infectious Diseases and Internal Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOBLOTTING; PRIORITY JOURNAL; REVIEW; SEROLOGY;

EID: 0023943197     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(12)64860-5     Document Type: Article

References (52)

1. Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome
2. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
3. Status report on the acquired immunodeficiency syndrome: human T-cell lymphotropic virus type III testing
4. Licensed tests for antibody to human T-lymphotropic virus type III: sensitivity and specificity
5. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
6. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS
7. Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources
8. Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk
9. Testing for human immunodeficiency virus (editorial)
10. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection
11. A pathogenic retrovirus (HTLV-III) linked to AIDS
12. Transfusion-associated acquired immunodeficiency syndrome: evidence for persistent infection in blood donors
13. HTLV-III in symptom-free seronegative persons
14. Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men
15. Antigens of human T-lymphotropic virus type III/lymphadenopathy associated virus
16. Envelope gene-derived recombinant peptide in the serodiagnosis of human immunodeficiency virus infection (letter to the editor)
17. Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody
18. Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide: comparison to Western blot on 2707 consecutive serum samples
19. Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications
20. Serological characterization of HTLV-III infection in AIDS and related disorders
21. Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III
22. Predictive value of a screening test for antibodies to HTLV-III
23. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS, and in groups at risk for AIDS
24. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS
25. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS
26. Anti-genemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection
27. Which anti-HTLV III/LAV assays for screening and confirmatory testing?
28. False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis (letter to the editor)
29. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results
30. Screening and diagnostic performance of enzyme immunoassay for antibody to lymphadenopathy-associated virus
31. Seroimmunology of AIDS retrovirus infection. I. Use of immunofluorescence assay to confirm sera with ELISA reactivity
32. Indirect immunofluorescence assay for antibodies to human immunodeficiency virus
33. Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus
34. False-positive Western blot tests for antibodies to HTLV-III (letter to the editor)
35. Primary human T-lymphotropic virus type III infection
36. Needlestick transmission of HTLV-III from a patient infected in Africa
37. Update: Human immunodeficiency virus infections in health-care workers exposed to blood of infected patients
38. Importance of Western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood
39. Lymphadenopathy syndrome in two thalassemic patients after LAV contamination by blood transfusion (letter to the editor)
40. HTLV-III infection associated with glandular-fever-like illness in a haemophiliac (letter to the editor)
41. Acute encephalopathy coincident with seroconversion for anti-HTLV-III
42. Acute AIDS retrovirus infection: definition of a clinical illness associated with seroconversion
43. Antibody response to human immunodeficiency virus after primary infection
44. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III (letter to the editor)
45. Low sensitivity of ELISA testing in early HIV infection (letter to the editor)
46. Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus